Search research articles
Contact Us
Filters
Showing results (501-510 of 7,076) with videos related to
Page
of 708
Sort By:
Drugs
|
February 17, 1998
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders
N S Gunasekara, S Noble, P Benfield
Drugs
|
February 17, 1998
Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders
A Prakash, P Benfield
Drugs
|
March 4, 1998
Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease
R G Fariello
Drugs
|
January 1, 1997
Anti-gram-positive agents. What we have and what we would like
R N Grüneberg
Drugs
|
January 1, 1997
Liposomes. Opportunities in drug delivery
T M Allen
Drugs
|
January 1, 1997
Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers
F M Muggia
Drugs
|
January 1, 1997
Safety aspects of pegylated liposomal doxorubicin in patients with cancer
D S Alberts, D J Garcia
Drugs
|
January 1, 1997
The medical economics of stroke
T N Taylor
Drugs
|
January 9, 1998
Influenza vaccines. A reappraisal of their use
A M Palache
Drugs
|
January 9, 1998
Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension
J C Gillis, A Markham
Page
of 708
Search research articles
Search
Showing results (501-510 of 7,076) with videos related to
Sort By:
Page
of 708
Drugs
|
February 17, 1998
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders
N S Gunasekara, S Noble, P Benfield
Drugs
|
February 17, 1998
Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders
A Prakash, P Benfield
Drugs
|
March 4, 1998
Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease
R G Fariello
Drugs
|
January 1, 1997
Anti-gram-positive agents. What we have and what we would like
R N Grüneberg
Drugs
|
January 1, 1997
Liposomes. Opportunities in drug delivery
T M Allen
Drugs
|
January 1, 1997
Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers
F M Muggia
Drugs
|
January 1, 1997
Safety aspects of pegylated liposomal doxorubicin in patients with cancer
D S Alberts, D J Garcia
Drugs
|
January 1, 1997
The medical economics of stroke
T N Taylor
Drugs
|
January 9, 1998
Influenza vaccines. A reappraisal of their use
A M Palache
Drugs
|
January 9, 1998
Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension
J C Gillis, A Markham
Page
of 708